SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

AN1 Anagenics Limited

Consumer Defensive · Household & Personal Products · website
$0.01
52wk 0.00 – 0.01
Overall
49.9
Value
80.0
Growth
0.0
Health
69.2
Quality
43.1
Momentum
57.5
Dividend
—
Price
About Anagenics Limited

Anagenics Limited engages in the health, wellness, and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.

Price analytics

Returns

1 day 0.0%
1 week 0.0%
1 month 0.0%
3 months -14.3%
6 months 0.0%
1 year 50.0%
3 years -72.7%

Risk

Volatility (1y ann.) 117.9%
Beta vs ASX 200 0.49
Sharpe (1y) 0.83
VaR 95% (1-day) -12.5%
Max drawdown (1y) -37.5%
Off 1-year high -33.3%

Technicals

RSI(14) 100 OB
vs 50DMA -2.9%
vs 200DMA -3.5%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 80.0
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
64
Price / Book
90
Price / Sales
96
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 43.1
Return on equity
51
Return on assets
52
Operating margin
29
Net margin
40
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 57.5
6-month return vs ASX 200
100
Price vs 200-day average
38
Price vs 50-day average
35
Position in 52-week range
40

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$5.91M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
0.43
EV / EBITDA
9.75
Price / Book
1.50
ROE
10.2%
Operating margin
7.3%
Net margin
6.0%
Total cash
$577,429
Total debt
$33,192
Current ratio
5.27
Debt / Equity
0.01
Free cash flow
$-1.22M
Avg volume
192,736
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$4.75M
  • Gross profit$2.04M
  • Operating income-$1.32M
  • Net income-$1.24M
  • Diluted EPS-0.00
  • Free cash flow-$1.58M
  • Net debt$452.53K
Sector peers (Consumer Defensive)
TickerMkt cap P/EScore
WOW $46.85B 41.7 35.9
COL $30.95B 28.4 42.5
EDV $5.35B 99.3 24.2
A2M $4.86B 29.0 48.3
TWE $4.54B — 51.6
MTS $3.18B 11.6 48.9
BGA $1.92B 34.8 44.4
GNC $1.43B — 35.9